Hungary Issues Drug Subsidy List
Hungary's Ministry of Health has issued a list of medicines which can be prescribed with health insurance subsidies, and another which lists those which may be supplied free, reports MTI Econews.
It is expected that a considerable proportion of the 72 billion forint ($481.4 million) budget for medicine subsidies will be used for the free medicines scheme, according to the National Health Insurance Office.
In 1995, 20%-22% of the 67.7 billion forint budget went on drugs subsidies to those receiving free medicines. This year, the number of such people could double, following a decision to provide free drugs to patients with a monthly income below 9,600 forint. This could lead to 45%-50% of the total drug subsidy being spent on the free medicines scheme, reports MTI. 11.5 billion forint of the scheme will be financed by the central budget and the remainder by health insurance.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze